180 related articles for article (PubMed ID: 18706808)
1. Empirical antifungal therapy for patients with neutropenia and persistent fever: Systematic review and meta-analysis.
Goldberg E; Gafter-Gvili A; Robenshtok E; Leibovici L; Paul M
Eur J Cancer; 2008 Oct; 44(15):2192-203. PubMed ID: 18706808
[TBL] [Abstract][Full Text] [Related]
2. Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review.
Pechlivanoglou P; Le HH; Daenen S; Snowden JA; Postma MJ
J Antimicrob Chemother; 2014 Jan; 69(1):1-11. PubMed ID: 23975736
[TBL] [Abstract][Full Text] [Related]
3. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
Cordonnier C; Pautas C; Maury S; Vekhoff A; Farhat H; Suarez F; Dhédin N; Isnard F; Ades L; Kuhnowski F; Foulet F; Kuentz M; Maison P; Bretagne S; Schwarzinger M
Clin Infect Dis; 2009 Apr; 48(8):1042-51. PubMed ID: 19281327
[TBL] [Abstract][Full Text] [Related]
4. Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia.
Fung M; Kim J; Marty FM; Schwarzinger M; Koo S
PLoS One; 2015; 10(11):e0140930. PubMed ID: 26554923
[TBL] [Abstract][Full Text] [Related]
5. Routine versus selective antifungal administration for control of fungal infections in patients with cancer.
Gotzsche PC; Johansen HK
Cochrane Database Syst Rev; 2002; (2):CD000026. PubMed ID: 12076377
[TBL] [Abstract][Full Text] [Related]
6. Routine versus selective antifungal administration for control of fungal infections in patients with cancer.
Gotzsche PC; Johansen HK
Cochrane Database Syst Rev; 2000; (4):CD000026. PubMed ID: 11034669
[TBL] [Abstract][Full Text] [Related]
7. Routine versus selective antifungal administration for control of fungal infections in patients with cancer.
Gøtzsche PC; Johansen HK
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD000026. PubMed ID: 25188768
[TBL] [Abstract][Full Text] [Related]
8. Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections.
Blyth CC; Hale K; Palasanthiran P; O'Brien T; Bennett MH
Cochrane Database Syst Rev; 2010 Feb; 2010(2):CD006343. PubMed ID: 20166083
[TBL] [Abstract][Full Text] [Related]
9. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
Walsh TJ; Teppler H; Donowitz GR; Maertens JA; Baden LR; Dmoszynska A; Cornely OA; Bourque MR; Lupinacci RJ; Sable CA; dePauw BE
N Engl J Med; 2004 Sep; 351(14):1391-402. PubMed ID: 15459300
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of micafungin versus extensive azoles in the prevention and treatment of invasive fungal infections for neutropenia patients with hematological malignancies: A meta-analysis of randomized controlled trials.
Lee CH; Lin JC; Ho CL; Sun M; Yen WT; Lin C
PLoS One; 2017; 12(7):e0180050. PubMed ID: 28700646
[TBL] [Abstract][Full Text] [Related]
11. Empirical antifungal therapy in treating febrile neutropenic patients.
Wingard JR
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S38-43. PubMed ID: 15250019
[TBL] [Abstract][Full Text] [Related]
12. Echinocandins versus non-echinocandins for empirical antifungal therapy in patients with hematological disease with febrile neutropenia: A systematic review and meta-analysis.
Yamashita C; Takesue Y; Matsumoto K; Ikegame K; Enoki Y; Uchino M; Miyazaki T; Izumikawa K; Takada T; Okinaka K; Ueda T; Miyazaki Y; Mayumi T
J Infect Chemother; 2020 Jun; 26(6):596-603. PubMed ID: 32171659
[TBL] [Abstract][Full Text] [Related]
13. Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
Tan BH; Low JG; Chlebicka NL; Kurup A; Cheah FK; Lin RT; Goh YT; Wong GC
Int J Infect Dis; 2011 May; 15(5):e350-6. PubMed ID: 21397541
[TBL] [Abstract][Full Text] [Related]
14. Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial.
Viscoli C; Castagnola E; Van Lint MT; Moroni C; Garaventa A; Rossi MR; Fanci R; Menichetti F; Caselli D; Giacchino M; Congiu M
Eur J Cancer; 1996 May; 32A(5):814-20. PubMed ID: 9081359
[TBL] [Abstract][Full Text] [Related]
15. Primary Fungal Prophylaxis in Hematological Malignancy: a Network Meta-Analysis of Randomized Controlled Trials.
Lee CH; Lin C; Ho CL; Lin JC
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866872
[TBL] [Abstract][Full Text] [Related]
16. [Empirical antifungal therapy in patients with febrile neutropenia].
Nucci M
Drugs Today (Barc); 2010 Apr; 46 Suppl C():13-20. PubMed ID: 20490378
[TBL] [Abstract][Full Text] [Related]
17. A prospective, randomized study of empirical antifungal therapy for the treatment of chemotherapy-induced febrile neutropenia in children.
Caselli D; Cesaro S; Ziino O; Ragusa P; Pontillo A; Pegoraro A; Santoro N; Zanazzo G; Poggi V; Giacchino M; Livadiotti S; Melchionda F; Chiodi M; Aricò M
Br J Haematol; 2012 Jul; 158(2):249-255. PubMed ID: 22571507
[TBL] [Abstract][Full Text] [Related]
18. Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis.
Robenshtok E; Gafter-Gvili A; Goldberg E; Weinberger M; Yeshurun M; Leibovici L; Paul M
J Clin Oncol; 2007 Dec; 25(34):5471-89. PubMed ID: 17909198
[TBL] [Abstract][Full Text] [Related]
19. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
Walsh TJ; Pappas P; Winston DJ; Lazarus HM; Petersen F; Raffalli J; Yanovich S; Stiff P; Greenberg R; Donowitz G; Schuster M; Reboli A; Wingard J; Arndt C; Reinhardt J; Hadley S; Finberg R; Laverdière M; Perfect J; Garber G; Fioritoni G; Anaissie E; Lee J;
N Engl J Med; 2002 Jan; 346(4):225-34. PubMed ID: 11807146
[TBL] [Abstract][Full Text] [Related]
20. Empirical antifungal therapy in patients with neutropenia and persistent or recurrent fever of unknown origin.
Martino R; Viscoli C
Br J Haematol; 2006 Jan; 132(2):138-54. PubMed ID: 16398648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
